MedTrace Logo

Perspective-taking, and Examining the Clinical Trial Informed Consent Process

NCT01778582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-12-09

No results posted yet for this study

Summary

Background:

\- Very few people with cancer participate in clinical trials. Some are uncertain about the treatment, or are afraid of being treated like a guinea pig. They may also feel that they have inadequate information about the trial. One possible way of encouraging people to sign up for clinical trials is to improve the informed consent process. Researchers want to understand how people read and understand informed consent documents.

Objectives:

\- To study perspective taking, and to study how people understand the information and enrollment process for a clinical trial.

Eligibility:

\- Healthy volunteers at least 18 years of age.

Design:

* This study will require one study visit.
* Participants will watch one of four movie clips. They will be asked to respond to the film by looking at it from the main character s perspective. They will then answer questions about how the clips made them feel.
* Participants will read a sample cancer clinical trial consent form on a computer. The computer will record their eye movements while they read the text. They will then be asked whether they remember the information in the consent form, and whether they would participate in the trial.
* No treatment will be provided as part of this study.

Conditions

  • Emotions
  • Informed Consent

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Rebecca A Ferrer, Ph.D. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-15
Primary Completion
2013-10-01
Completion
2013-10-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01778582 on ClinicalTrials.gov